Alexza to Raise $18.0M in Registered Direct Offering
Alexza to raise .0M in registered direct offering
Alexza Pharmaceuticals, Inc. today announced that it has entered into definitive agreements with a select group of institutional investors to raise approximately $ 18.0 million in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 6,685,183 units, each unit consisting of (i) one share of common stock and (ii) one …
Read more on News-Medical-Net